Klinische Diagnostik

Literatur

• 1 Rao S S, Holdsworth C D, Read N W. Symptoms and stool patterns in patients with ulcerative colitis.  Gut. 1988;  29 342-345 (IIb)
• 2 Both H, Torp-Pedersen K, Kreiner S. et al . Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patient group.  Scand J Gastroenterol. 1983;  18 987-991 (IIb)
• 3 Drossman D A, Li Z, Leserman J. et al . Ulcerative colitis and Crohn’s disease health status scales for research and clinical practice.  J Clin Gastroenterol. 1992;  15 104-112 (IIb)
• 4 Rath H C, Caesar I, Roth M. et al . Mangelzustände und Komplikationen bei chronisch entzündlichen Darmerkrankungen.  Med Klin. 1998;  93 6-10 (IIb)
• 5 Powell-Tuck J, Day D W, Buckell N A. et al . Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.  Dig Dis Sci. 1982;  27 533-537 (IIb)
• 6 Gomes P, du B oulay C, Smith C L. et al . Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.  Gut. 1986;  27 92-95 (IIb)
• 7 Seo M, Okada M, Maeda K. et al . Correlation between endoscopic severity and the clinical activity index in ulcerative colitis.  Am J Gastroenterol. 1998;  93 2124-2129 (IIb)
• 8 Vatay A, Bene L, Kovacs A. et al . Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.  Immunogenetics. 2003;  55 247-252 (IIb)
• 9 Descos L, Andre F, Andre C. et al . Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis.  Digestion. 1983;  28 148-152 (IIb)
• 10 Moran A, Jones A, Asquith P. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn’s colitis.  Scand J Gastroenterol. 1995;  30 356-360 (IIb)
• 11 Bunn S K, Bisset W M, Main M J. et al . Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.  J Pediatr Gastroenterol Nutr. 2001;  32 171-177 (III)
• 12 Tibble J A, Sigthorsson G, Bridger S. et al . Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.  Gastroenterology. 2000;  119 15-22 (IIa)
• 13 Roseth A G, Schmidt P N, Fagerhol M K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.  Scand J Gastroenterol. 1999;  34 50-54 (III)
• 14 Kayazawa M, Saitoh O, Kojima K. et al . Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.  Am J Gastroenterol. 2002;  97 360-369 (IIb)
• 15 Kane S V, Sandborn W J, Rufo P A. et al . Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.  Am J Gastroenterol. 2003;  98 1309-1314 (Ib)
• 16 Carroccio A, Iacono G, Cottone M. et al . Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children.  Clin Chem. 2003;  49 861-867 (Ib)
• 17 Sandborn W J, Loftus E V Jr, Colombel J F. et al . Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s disease.  Inflamm Bowel Dis. 2001;  7 192-201 (IIb)
• 18 Joossens S, Reinisch W, Vermeire S. et al . The value of serologic markers in indeterminate colitis: a prospective follow-up study.  Gastroenterology. 2002;  122 1242-1247 (IIa)
• 19 Dubinsky M C, Ofman J J, Urman M. et al . Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.  Am J Gastroenterol. 2001;  96 758-765 (IIb)
• 20 O’Morain C, Tobin A, Leen E. et al . Criteria of case definition in Crohn’s disease and ulcerative colitis.  Scand J Gastroenterol Suppl. 1989;  170: 7 - 11; discussion 16 - 19 (IIb)
• 21 Boom R, Sol C, Weel J. et al . Detection and quantitation of human cytomegalovirus DNA in faeces.  J Virol Methods. 2000;  84 1-14 (IIb)
• 22 Cottone M, Pietrosi G, Martorana G. et al . Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis.  Am J Gastroenterol. 2001;  96 773-775 (III)
• 23 Adani G L, Avital I, Ferraresso C. et al . CMV infection in severe refractory ulcerative and Crohn’s colitis.  Am J Gastroenterol. 2001;  96 3464-3465 (IV)
• 24 Cooper H S, Raffensperger E C, Jonas L. et al . Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.  Gastroenterology. 1977;  72 1253-1256 (III)
• 25 Papadakis K A, Tung J K, Binder S W. et al . Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.  Am J Gastroenterol. 2001;  96 2137-2142 (III)
• 26 Kaufman H S, Kahn A C, Iacobuzio-Donahue C. et al . Cytomegaloviral enterocolitis: clinical associations and outcome.  Dis Colon Rectum. 1999;  42 24-30 (IIb)
• 27 Lee S D, Cohen R D. Endoscopy in inflammatory bowel disease.  Gastroenterol Clin North Am. 2002;  31 119-132 (IV)
• 28 Rutgeerts P, Peeters M, Geboes K. et al . Infectious agents in inflammatory bowel disease.  Endoscopy. 1992;  24 565-567 (IV)
• 29 Horing E, Gopfert D, Schroter G. et al . Frequency and spectrum of microorganisms isolated from biopsy specimens in chronic colitis.  Endoscopy. 1991;  23 325-327 (IIb)
• 30 Caradonna L, Amati L, Magrone T. et al . Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.  J Endotoxin Res. 2000;  6 205-214 (IIb)
• 31 D’Haens G, Geboes K, Peeters M. et al . Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.  Am J Gastroenterol. 1997;  92 1275-1279 (IIb)
• 32 Hill M D, Davies G, McIntyre A S. et al . Proctitis with caecitis: an atypical presentation of ulcerative colitis.  Endoscopy. 2002;  34 664-666 (IV)
• 33 Heuschen U A, Hinz U, Allemeyer E H. et al . Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.  Gastroenterology. 2001;  120 841-847 (IIb)
• 34 Kleer C G, Appelman H D. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.  Am J Surg Pathol. 1998;  22 983-989 (IIb)
• 35 Geboes K, Ectors N, D’Haens G. et al . Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease?.  Am J Gastroenterol. 1998;  93 201-206 (IIb)
• 36 Pera A, Bellando P, Caldera D. et al . Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score.  Gastroenterology. 1987;  92 181-185 (IIb)
• 37 Floren C H, Benoni C, Willen R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis.  Scand J Gastroenterol. 1987;  22 459-462 (IIb)
• 38 Riley S A, Mani V, Goodman M J. et al . Microscopic activity in ulcerative colitis: what does it mean?.  Gut. 1991;  32 174-178 (IIb)
• 39 Dejaco C, Oesterreicher C, Angelberger S. et al . Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis.  Endoscopy. 2003;  35 1004-1008 (IIb)
• 40 Moum B, Ekbom A, Vatn M H. et al . Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.  Am J Gastroenterol. 1999;  94 1564-1569 (IIb)
• 41 Fernandez-Banares F, Salas A, Esteve M. et al . Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.  Am J Gastroenterol. 2003;  98 340-347 (IIb)
• 42 Shah R J, Fenoglio-Preiser C, Bleau B L. et al . Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea.  Am J Gastroenterol. 2001;  96 1091-1095 (III)
• 43 Yusoff I F, Ormonde D G, Hoffman N E. Routine colonic mucosal biopsy and ileoscopy increases diagnostic yield in patients undergoing colonoscopy for diarrhea.  J Gastroenterol Hepatol. 2002;  17 276-280 (III)
• 44 Levine T S, Tzardi M, Mitchell S. et al . Diagnostic difficulty arising from rectal recovery in ulcerative colitis.  J Clin Pathol. 1996;  49 319-323 (III)
• 45 Markowitz J, Kahn E, Grancher K. et al . Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis.  Am J Gastroenterol. 1993;  88 2034-2037 (III)
• 46 Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making.  Am J Gastroenterol. 1991;  86 187-190 (IIb)
• 47 Carbonnel F, Lavergne A, Lemann M. et al . Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.  Dig Dis Sci. 1994;  39 1550-1557 (III)
• 48 Swan N C, Geoghegan J G, O’Donoghue D P. et al . Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis.  Dis Colon Rectum. 1998;  41 1511-1515 (IIb)
• 49 Meucci G, Bortoli A, Riccioli F A. et al . Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).  Eur J Gastroenterol Hepatol. 1999;  11 909-913 (IIb)
• 50 Moum B, Ekbom A, Vatn M H. et al . Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.  Gut. 1997;  40 328-332 (IIb)
• 51 Jaramillo E, Watanabe M, Befrits R. et al . Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy.  Gastrointest Endosc. 1996;  44 15-22 (IIb)
• 52 Matsumoto T, Kuroki F, Mizuno M. et al . Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis.  Gastrointest Endosc. 1997;  46 400-405 (III)
• 53 Tung S Y, Wu C S, Su M Y. Magnifying colonoscopy in differentiating neoplastic from nonneoplastic colorectal lesions.  Am J Gastroenterol. 2001;  96 2628-2632 (IIb)
• 54 Kiesslich R, Fritsch J, Holtmann M. et al . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888 (Ib)
• 55 Schwerk W BBK, Raith M. A prospective evaluation of high resolution sonography in the diagnosis of inflammatory bowel disease.  Eur J Gastroenterol Hepatol. 1992;  172-182 (IIb)
• 56 Gumaste V, Sachar D B, Greenstein A J. Benign and malignant colorectal strictures in ulcerative colitis.  Gut. 1992;  33 938-941 (IIb)
• 57 Oberhuber G, Puspok A, Oesterreicher C. et al . Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease.  Gastroenterology. 1997;  112 698-706 (IIb)
• 58 Parente F, Cucino C, Bollani S. et al . Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.  Am J Gastroenterol. 2000;  95 705-711 (IIb)
• 59 Hollerbach S, Geissler A, Schiegl H. et al . The accuracy of abdominal ultrasound in the assessment of bowel disorders.  Scand J Gastroenterol. 1998;  33 1201-1208 (IIb)
• 60 Arienti V, Campieri M, Boriani L. et al . Management of severe ulcerative colitis with the help of high resolution ultrasonography.  Am J Gastroenterol. 1996;  91 2163-2169 (IIb)
• 61 Parente F, Greco S, Molteni M. et al . Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel.  Aliment Pharmacol Ther. 2003;  18 1009-1016 (IIb)
• 62 Haber H P, Busch A, Ziebach R. et al . Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides.  J Ultrasound Med. 2002;  21 375-382 (III)
• 63 Bru C, Sans M, Defelitto M M. et al . Hydrocolonic sonography for evaluating inflammatory bowel disease.  AJR Am J Roentgenol. 2001;  177 99-105 (IIb)
• 64 Limberg B. [Diagnosis of chronic inflammatory bowel disease by ultrasonography].  Z Gastroenterol. 1999;  37 495-508 (IV)
• 65 Kalantzis N, Rouvella P, Tarazis S. et al . Doppler US of superior mesenteric artery in the assessment of ulcerative colitis. A prospective study.  Hepatogastroenterology. 2002;  49 168-171 (IIa)
• 66 Maconi G, Imbesi V, Bianchi Porro G. Doppler ultrasound measurement of intestinal blood flow in inflammatory bowel disease.  Scand J Gastroenterol. 1996;  31 590-593 (IIb)
• 67 Sigirci A, Baysal T, Kutlu R. et al . Doppler sonography of the inferior and superior mesenteric arteries in ulcerative colitis.  J Clin Ultrasound. 2001;  29 130-139 (IIb)
• 68 Ludwig D, Wiener S, Bruning A. et al . Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.  Gut. 1999;  45 546-552 (IIa)
• 69 Higaki S, Nohara H, Saitoh Y. et al . Increased rectal wall thickness may predict relapse in ulcerative colitis: a pilot follow-up study by ultrasonographic colonoscopy.  Endoscopy. 2002;  34 212-219 (IIb)
• 70 Gast P, Belaiche J. Rectal endosonography in inflammatory bowel disease: differential diagnosis and prediction of remission.  Endoscopy. 1999;  31 158-166 (III)
• 71 Dagli U, Over H, Tezel A. et al . Transrectal ultrasound in the diagnosis and management of inflammatory bowel disease.  Endoscopy. 1999;  31 152-157 (III)
• 72 Ajaj W, Pelster G, Treichel U. et al . Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology.  Gut. 2003;  52 1738-1743 (III)
• 73 Sardanelli F, de Cicco E, Renzetti P. et al . Double-contrast magnetic resonance examination of ulcerative colitis.  Eur Radiol. 1999;  9 875-879 (IIa)
• 74 Shoenut J P, Semelka R C, Magro C M. et al . Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease.  J Clin Gastroenterol. 1994;  19 31-35 (IIb)
• 75 Madsen S M, Thomsen H S, Munkholm P. et al . Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99 mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery.  Scand J Gastroenterol. 2002;  37 307-316 (IIb)
• 76 Albert J, Scheidt T, Basler B. et al . [Magnetic Resonance Imaging in diagnosis and follow-up of Crohn’s Disease - Is conventional enteroclysis still necessary?].  Z Gastroenterol. 2002;  40 789-794 (IIb)
• 77 Rieber A, Nussle K, Reinshagen M. et al . MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease.  Abdom Imaging. 2002;  27 394-399 (IV)
• 78 Hansmann H J, Hess T, Hahmann M. et al . [MRI in chronic inflammatory bowel disease].  Fortschr Röntgenstr. 2001;  173 4-11 (IV)
• 79 Voderholzer W A, Ortner M, Rogalla P. et al . Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis.  Endoscopy. 2003;  35 1009-1014 (IIb)
• 80 Fireman Z, Mahajna E, Broide E. et al . Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy.  Gut. 2003;  52 390-392 (IIb)
• 81 Eliakim R, Fischer D, Suissa A. et al . Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn’s disease.  Eur J Gastroenterol Hepatol. 2003;  15 363-367 (IIb)
• 82 Grahnquist L, Chapman S C, Hvidsten S. et al . Evaluation of 99 mTc-HMPAO leukocyte scintigraphy in the investigation of pediatric inflammatory bowel disease.  J Pediatr. 2003;  143 48-53 (IIb)